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Objective: To determine the prevalence of dry eye symptoms and signs in children with 
juvenile idiopathic arthritis (JIA).
Patients and methods: A total of 192 children with JIA: 48 oligo-, 39 extended oligo-, 
79 polyarthritis, and 26 with other types of arthritis (eight juvenile spondyloarthritis, ﬁ  ve juvenile 
psoriatic arthritis, three mixed connective tissue diseases, two systemic onset arthritis, and eight 
undetermined arthritis) were interviewed for dry eye symptoms and tested with Schirmer test 
with anesthetic. Two thirds of the patients were female and the mean age of the patients was 
13.1 years (range 10–16) and the mean duration of arthritis was six years (SD 4, 4). Thirty-one 
percent of the patients had a history of uveitis. Dry eye was deﬁ  ned as Schirmer test score   5 mm 
in ﬁ  ve minutes. The type of arthritis, a history of uveitis, and the ocular and systemic medication 
used were evaluated for their correlation with dry eye symptoms and signs by using chi-square 
tests and the Mann–Whitney Monte Carlo analysis.
Results: Altogether 17% of this cohort had decreased basal tear secretion. The most com-
mon symptoms of dry eye were discharge secretion, itching, and watering. The intensity of 
symptoms and signs did not correlate. The type of arthritis, a history or presence of uveitis, and 
the medication used did not correlate with the occurrence of dry eyes.
Conclusion: Dry eye symptoms and signs are common in JIA, and Schirmer test with anesthetic 
is a useful tool in evaluating these patients.
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Introduction
The most common extra-articular manifestation of juvenile idiopathic arthritis (JIA) 
is chronic insidious uveitis occurring in 20% of patients.1 The widely known risk 
factors of uveitis are a young age at the onset of arthritis, oligoarthritis, and positive 
antinuclear antibodies (ANA).2 Less known is the role of dry eye syndrome in JIA. 
Severe aqueous tear deﬁ  ciency leading to keratoconjunctivitis sicca (KCS) is assumed 
to be rare in childhood. Sjögren’s syndrome (SS) with symptoms of dry eyes and dry 
mouth is seldom seen in children: the prevalence is assumed to be about 5% in juvenile 
rheumatic diseases.3–5
Because some of our JIA patients complained of discomfort in their eyes, we 
decided to screen for possible dry eye symptoms and signs by biomicroscopy, the 
Schirmer test with anesthetic, and by making a symptoms inquiry to a large clinic-
based cohort of 192 consecutive JIA patients in their early teens.
Patients and methods
The study was conducted at The Rheumatism Foundation Hospital, Heinola, Finland, 
which is a tertiary center for rheumatic patients for the whole country and a secondary 
center for those living in the neighborhood.Clinical Ophthalmology 2009:3 272
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All the JIA children, born in 1990–1995, whose 
diagnoses of JIA were made by a pediatric rheumatologist 
at this hospital and who were examined between September 
2005 and December 2006, were included in this study. The 
diagnosis of arthritis was made according to International 
League of Associations for Rheumatology classiﬁ  cation and 
the diagnosis of uveitis was made according to the Interna-
tional Uveitis Study Group guidelines.6,7 The patients were 
systematically and regularly (every 2 to 6 months) sent for 
an ophthalmologic evaluation for detection/exclusion of 
insidious uveitis, as recommended.1,2 The examination for 
dry eye symptoms and signs was performed once to every 
patient during these visits.
Every patient underwent a comprehensive ophthalmo-
logic examination including the best corrected visual acuity, 
biomicroscopy, examination of the posterior parts of the 
eyes with a 90 diopter Volk lens, as well as an inspection of 
the outer parts of the eyes and eye lids. The corneal surface 
was examined in biomicroscopy by authors KK or KS-K 
with/without staining with ﬂ  uorescein to look for the dry 
spots of the cornea, marginal tear meniscus, and stability 
of the tear ﬁ  lm.
A registered nurse (PS) was responsible for the patient 
interview and the Schirmer test. A Schirmer test was per-
formed after the biomicroscopy of the eyes. Five minutes 
after the instillation of anesthetic drops (Oftan ObucainR, 
Santen, Finland) in both eyes, 35-mm regular Schirmer test 
strips were placed in the outer third of the inferior fornix of 
both eyes while the patient was in a sitting position. The test 
was regarded as positive if the strips became moist  5 mm 
downwards from the eye lid margins in ﬁ  ve minutes.
The patients were asked about their dry eye symptoms: 
itching, smarting, foreign body sensation, watering, discharge 
secretion, and redness, which were graded 0–3, maximum 18; 
0 no symptoms, 1 mild, 2 moderate, 3 severe symptoms.
A re-inquiry of symptoms and signs was made to 
158 patients in connection with their subsequent visits 
6 to 18 months later.
Statistics
Statistical signiﬁ  cance between groups was evaluated by 
Mann–Whitney test (Monte Carlo p-value), chi-square test 
or Fisher–Freeman–Halton test.
Ethics
The study protocol was approved by the local Institutional 
Ethics Committee.
Results
The demographic data of the patients are described in Table 1. 
The group of “other arthritis” consisted of eight patients 
with juvenile spondyloarthritis, ﬁ  ve with juvenile psoriatic 
arthritis, three with mixed connective tissue disease, two with 
systemic onset arthritis, and eight with undetermined arthritis. 
Most of the patients, 91% (174/192), had active arthritis at 
the time of the study. The mean age of the patients at the 
onset of JIA was 7.1 years (range 1–15) and at the time of 
the study 13.1 years (range 10–16) after the mean follow-up 
time of six years (SD 4.4).
Chronic uveitis had been a feature of the disease 
in 61 cases (31%). Most of these, 44 (72%), had ongoing 
topical corticosteroid treatment (dexamethasone or pred-
nisolone acetate) for uveitis and 13 had undergone cataract 
or glaucoma surgery.
A total of 17% (32/192) of the patients had decreased 
basal tear secretion (Schirmer value  5 mm in ﬁ  ve minutes 
Table1 Demographic data of 192 patients with juvenile idiopathic arthritis (JIA)
Variables Course type of arthritis
Oligo N = 48 Extended oligo N = 39 Poly N = 79 Other N = 26
Number of girls, (%) 29 (60) 25 (64) 57 (72) 14 (54)
Mean age at onset of JIA, (range) 7.3 (1.1–15.8) 5.3 (0.8–12.9) 6.8 (1.1–15.3) 10.2 (2.8–15.2)
Mean age at examination, (range) 12.9 (10.1–15.8) 13.1 (10.5–15.9) 13.1 (10.3–16.0) 13.6 (10.3–16.0)
Onset type of arthritis, n (%)
  Oligoarthritis 48 (25) 39 (20) 0 5 (3)
  Polyarthritis 0 0 79 (41) 1 (0.5)
  Other arthritis 0 0 0 20 (10)
ANA positivity, n (%) 21 (44) 23 (59) 45 (57) 6 23)
Occurrence of uveitis, n (%) 19 (40) 12 (31) 27 (35) 3 (12)Clinical Ophthalmology 2009:3 273
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after anesthetic drops) in both eyes and their mean symptom 
score was 5.3 (range 0–11).
Twenty percent of the patients with a history of uveitis 
and 15% of those without had Schirmer test result  5 mm 
in both eyes (p = 0.45) and the mean score of symptoms 
6.1 (range 1–11) and 4.9 (range 0–11), respectively. These 
patients did not signiﬁ  cantly differ from each other with 
regard to the dry eye symptoms or signs (p = 0.62). The 
mean Schirmer values according to the eye with a smaller 
tear secretion were 11.0 (range 0–29, SD 8.6) in patients 
with a history of uveitis and 13.0 (range 0–35, SD 10) in 
patients without uveitis.
As many as 35% (67/192) of the whole study group had 
the Schirmer test value  10 mm in ﬁ  ve minutes in both 
eyes and the mean symptom score of 5.3 (range 0–14). The 
Schirmer test results in the four patient groups did not mark-
edly (p = 0.34) differ from each other as seen in Figure 1.
The medical therapy was not associated with decreased 
tear secretion. Fifty-seven (93%) of the 61 patients with a 
history of uveitis and 116 (89%) of those without uveitis used 
disease-modifying antirheumatic drugs (DMARDs) at the 
time of the study (Table 2). Methotrexate was used as often 
in patients with low Schirmer test values as in those with 
normal results. Biologic agents were similarly used in both 
groups and so was systemic glucocorticoid treatment.
Altogether 94% of the patients reported one or more of 
the dry eye symptoms. The occurrence of eye symptoms in 
patients with decreased tear secretion as compared to those 
with normal tear secretion is described in Table 3. The 
32 patients with low Schirmer test values ( 5 mm) in both 
eyes had the mean intensity of symptoms at 5.3 (range 0–11) 
compared to the value of 5.2 (range 0–16) in the 160 with 
the Schirmer test value  5 mm (ns).
Most of the patients in our study had normal tear ﬁ  lm 
stability when evaluated by biomicroscopy between blinks. 
None of the patients had ﬁ  laments on the cornea, although 
in some cases a few dry spots were seen in the lower corneal 
epithelium after staining with ﬂ  uorescein.
Discussion
A total of 17% of the patients had the Schirmer test value 
 5 mm and 35% had  10 mm in both eyes. The number of 
patients with low basal tear secretion was somewhat higher 
among children with uveitis than among those without a 
history of uveitis (20% vs. 15%) but the difference was not 
signiﬁ  cant. The course type of arthritis or the medication 
used had no impact on dry eyes.
In adult-onset SS dryness of the eyes occurs in up to 90% 
of patients.3,4,10 This disease is rare in childhood, which may 
explain the fact that there are few papers concerning the 
dry eye problem in JIA.8 In our earlier epidemiologic study 
of young adults with JIA, 40% of the patients with uveitis 
and 26% (ns) of those without had dry eye symptoms and 
the Schirmer test with anesthetic  10 mm/5 min in either 
eye.11 In the present study no great difference was found 
in the Schirmer test with cut-off value  10 mm/5 min 
(41% vs. 35%, respectively) between patients with or without 
a history of uveitis. Perhaps the longer duration of uveitis 
and arthritis in the former study explains it.
According to a report from India, 12% of 50 JIA children 
had KCS.9 Their patient cohort was different from the one 
in the present study, as most of the patients were male, had 
polyarthritis and a ﬁ  fth of the cohort had systemic-onset 
arthritis. Children with corticosteroid treatment or topical 
treatment for uveitis were excluded. Their cut-off value in 
the Schirmer test was  10 mm in ﬁ  ve minutes. A study from 
Turkey describes the occurrence of KCS in 64 JIA patients 
and controls.10 Dry eye symptoms and signs with the cut-off 
value  5 mm were found in 12.5% and 10.9% of the patients, 
respectively, compared to 1.5% and 1.5% of the controls. 
Diagnosis (course type)
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Figure 1 The occurrence of low Schirmer test values  5 mm in both eyes in the four 
different diagnostic groups of 192 juvenile idiopathic arthritis patients.Clinical Ophthalmology 2009:3 274
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Also, in that study patients with systemic glucocorticoid 
treatment, topical ocular treatment and previous ocular laser 
or surgical treatment were excluded.
In the present study, we included all the 192 consecutive 
JIA patients born in 1990–1995 who visited both a pediatric 
rheumatologist and an ophthalmologist during the study 
period and who thus formed a cross-sectional age group. In 
our study, the mean duration of arthritis was six years, and 
the majority of the patients had ongoing medical treatment 
for arthritis. Chronic asymptomatic anterior uveitis was also 
a frequent feature of the disease in the study group (31%). 
Patients with JIA complain of aches or discomfort in their 
joints less often than adults. Perhaps that is the reason why 
they seldom spontaneously report any symptoms of dry eyes 
if not particularly asked about them. The lack of association 
between signs and symptoms of dry eyes in JIA children has 
earlier been reported by Nichols and colleauges.12 Because 
the treatment was applied according to the intensity of 
symptoms of dryness only a small proportion of the patients 
needed artiﬁ  cial tears. A re-inquiry was made to 158 patients 
at their further control visits and 23% (36) of them had used 
artiﬁ  cial tears; 50% (18/36) of them had the Schirmer test 
result  5 mm/5 min in either eye, whereas 21% (26/122) 
of those who had not used artiﬁ  cial tears, had the same test 
result.
We describe here the practical screening of dry eyes 
by the Schirmer test with an anesthetic and by a symptoms 
inquiry as a part of clinical examination of JIA patients. 
In connection with the Schirmer test, patients were also 
instructed on of the use of the treatment modalities for dry 
eyes. More extensive tests may be needed only in cases with 
low Schirmer value combined with marked symptoms or 
signs of dry eyes. Rose Bengal dye is very irritating to dry 
eyes and we seldom use it nowadays. More extensive testing 
was also limited because of the young age of the patients.
Dry eye symptoms and signs are common in JIA. 
A symptoms inquiry and Schirmer test with anesthetic are 
useful tools for pediatric rheumatologists/rheumatologists in 
managing these patients.
Disclosure
The authors report no conﬂ  icts of interest in this work.
Table 2 Treatment of 192 juvenile idiopathic arthritis patients at the time of ophthalmic screening.  A combination of drugs was frequently 
used
Medication Shirmer test
0–5 mm N = 32 N (%)  5 mm N = 160 N (%)
Methotrexate 20 (62) 95 (59)
Hydroxychloroquine 14 (44) 55 (34)
Leﬂ  unomide 6 (19) 26 (16)
Prednisolone (systemic) 4 (13) 25 (16)
Sulphasalazine 1 (3) 20 (12)
Azathioprine 1 (3) 12 (8)
Cyclosporine 1 (3) 6 (4)
Biologic drugs* 12 (38) 71 (44)
Dexamethasone or prednisolone acetate eye drops 6 (19) 23 (14)
Notes: *Inﬂ  iximab, adalimumab, etanercept, anakinra.
Table 3 The occurrence of eye symptoms in 192 juvenile idiopathic arthritis patients with positive and negative Schirmer test values 
in both eyes
Symptoms Schirmer test P value
0–5 mm N = 32  5 mm N = 160
Itching, n (%) 16 (50) 54 (34) 0.081
Burning, n (%) 3 (9) 20 (13) 0.62
Foreign body sensation, n (%) 11 (34) 57 (36) 0.89
Watering, n (%) 12 (38) 57 (36) 0.84
Discharge, n (%) 15 (47) 66 (41) 0.56
Redness, n (%) 8 (25) 28 (18) 0.32Clinical Ophthalmology 2009:3 275
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